Crinetics Pharmaceuticals (CRNX) Free Cash Flow (QoQ) (2017 - 2026)
Crinetics Pharmaceuticals (CRNX) Free Cash Flow (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 973.81 Bn | 973.81 Bn | - |
| 4 | BeOne Medicines | 471.51 Bn | 466.72 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.70 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.88 Bn | 50.69 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Crinetics Pharmaceuticals | 8.73 Bn | 7.44 Bn | 10.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.25% |
| Dec 31, 2025 | 12.32% |
| Sep 30, 2025 | -18.11% |
| Jun 30, 2025 | -1.48% |
| Mar 31, 2025 | -25.57% |
| Dec 31, 2024 | -12.98% |
| Sep 30, 2024 | -34.03% |
| Jun 30, 2024 | 13.89% |
| Mar 31, 2024 | -31.36% |
| Dec 31, 2023 | 1.14% |
| Sep 30, 2023 | 8.81% |
| Jun 30, 2023 | -12.33% |
| Mar 31, 2023 | -20.43% |
| Dec 31, 2022 | 14.97% |
| Sep 30, 2022 | -42.22% |
| Jun 30, 2022 | -105.22% |
| Mar 31, 2022 | 40.52% |
| Dec 31, 2021 | 12.17% |
| Sep 30, 2021 | -30.93% |
| Jun 30, 2021 | 0.80% |